VIVUS (VVUSQ) News Today $0.12 0.00 (0.00%) As of 12/17/2020 Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period VIVUS and UpScriptHealth Announce Launch of ChooseQ.online for Access to Advanced Weight Management SolutionsOctober 30, 2024 | markets.businessinsider.comVIVUS Announces Commercialization of QSIVA® in Sweden, Denmark, Finland, Iceland, Norway, and PolandOctober 7, 2024 | markets.businessinsider.comTimber Rattlesnake vs. Eastern Diamondback: What Sets These Fanged Serpents Apart?August 19, 2024 | msn.comIcahn Enterprises L.P. (NASDAQ:IEP) Q2 2024 Earnings Call TranscriptAugust 8, 2024 | msn.comWeight Loss Drugs Market Size to Hit US$ 45.35 Billion By 2032, With a Growing CAGR of 43.73% | Research by SNS InsiderJuly 23, 2024 | finance.yahoo.comPorsche's Hybrid 911 Is Finally Coming After 3 Million Miles Of TestingMay 14, 2024 | msn.comPorsche is debuting a new hybrid 911 sports carMay 13, 2024 | msn.comHybrid 911 Coming 2025, but Ferdinand Porsche Invented World's First Hybrid in 1899May 13, 2024 | msn.comFerdinand Porsche’s Gas-Electric Hybrid TanksApril 24, 2024 | yahoo.comVIVUS Announces it will Provide Telehealth to Patients through an Enhanced 'Engage' Program in Collaboration with UpScriptHealthApril 22, 2024 | finance.yahoo.comAnti-obesity Drugs market is estimated to grow at a CAGR of 21.2% by 2034: VisiongainApril 12, 2024 | uk.finance.yahoo.comUS pharma giant Eli Lilly plans to introduce its blockbuster anti-diabetes drug Mounjaro to India next year, to target weight loss marketFebruary 28, 2024 | msn.comWeight-loss drugs for teens are controversial. A 16-year-old taking Wegovy shares her storyFebruary 9, 2024 | msn.comThe First Porsche With All-Wheel Drive Was An Off-Road Military VehicleJanuary 27, 2024 | msn.comNorovirus, aka stomach flu, on the rise in the US: Know these signsJanuary 5, 2024 | msn.comGustav Mahler: Eighth Symphony: Part TwoDecember 30, 2023 | bbc.co.ukWhy pharma majors are rushing to put anti-obesity drugs on Indian shelvesDecember 23, 2023 | msn.comErectile Dysfunction (ED) Drugs Market to grow by USD 1.44 billion from 2023-2028, North America to account for 41% of market growth - TechnavioDecember 14, 2023 | finance.yahoo.comCaledon residents donate $500,000 to Headwaters Health Care FoundationDecember 7, 2023 | ca.news.yahoo.comWhat Is Barre? Everything to Know About This Low-Impact, High-Intensity WorkoutDecember 7, 2023 | ca.sports.yahoo.comTeens who use phones for over 4 hours daily face higher health risks: studyDecember 7, 2023 | ca.sports.yahoo.comCharlotte hospitals change visitor guidelines due to rising COVID-19, flu and RSV casesDecember 7, 2023 | ca.sports.yahoo.comHospital Pushed Weight-Loss Surgery on Prisoners Who Recovered in Jail: NYTDecember 7, 2023 | ca.news.yahoo.comFree at-home testing and treatments now available for COVID and flu through federal programDecember 6, 2023 | ca.sports.yahoo.comSaskatchewan auditor reports longer waits for neurosurgeries; more homelessnessDecember 6, 2023 | ca.news.yahoo.comBoris Johnson admits he should 'twigged the risk' of Covid earlierDecember 6, 2023 | ca.sports.yahoo.comThis Is How I Finally Got My Tubes Removed After Years Of Doctors Fighting Me On ItDecember 6, 2023 | ca.news.yahoo.comAdherence to weight-loss drugs is far higher with Wegovy than older medicinesDecember 6, 2023 | reuters.comAnti-Obesity Drugs Market is forecasted to reach USD 8.2 billion by 2032, growing at a 14.6% CAGR from 2023 to 2032October 3, 2023 | finance.yahoo.comWegovy, other weight-loss drugs scrutinized over reports of suicidal thoughtsSeptember 28, 2023 | reuters.comEU regulators warn pregnant women not to use topiramateSeptember 1, 2023 | msn.comStudy finds Wegovy least cost-effective drug option for teen weight lossAugust 31, 2023 | msn.comEU investigates Ozempic, weight-loss drug Saxenda after patients report suicidal thoughtsJuly 10, 2023 | theglobeandmail.comE.U. investigates Ozempic and weight-loss drug Saxenda after reports of suicidal thoughtsJuly 10, 2023 | nbcnews.comEU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reportedJuly 10, 2023 | msn.comYou Might Be Using Your 4-Wheel Drive Wrong – Here's The Right WayJuly 10, 2023 | msn.comHistoric Portsmouth vessel transformed into 1940s style restaurant offering views across The SolentJune 18, 2023 | msn.comFour Drug Stocks Facing FDA Approval Decisions in JulyJune 10, 2023 | thestreet.comOrexigen: 'Goldilocks' Obesity Pill Awaits FDA Approval Decision WednesdayMay 24, 2023 | thestreet.comVivus Lives to Fight Another DayMay 7, 2023 | thestreet.comPhosphodiesterase Inhibitors Market Size with Growth Opportunities, Future Trends and Share with Revenue Forecast 2028May 5, 2023 | marketwatch.comWhy VIVUS (VVUS) Stock Is Up TodayMay 2, 2023 | thestreet.comPhosphodiesterase Inhibitors Market Analysis By Industry Size, Development And Demand Forecast 2028March 27, 2023 | marketwatch.comVIVUS Announces Key Management Updates to Support Global Expansion StrategyFebruary 5, 2023 | finance.yahoo.comPhosphodiesterase Inhibitors Market Global Industry Analysis By Development, Industry Analysis and Opportunity Assessment 2028May 31, 2022 | marketwatch.comPhosphodiesterase Inhibitors Market Industry Analysis Technological Innovations, Trends, Growth And Opportunity Assessment 2028April 26, 2022 | marketwatch.comPhosphodiesterase Inhibitors Market: Industry Analysis and Opportunity Assessment 2028January 19, 2022 | marketwatch.comPhosphodiesterase Inhibitors Market Share, Latest Trend Analysis, Revenue Expectation to 2028December 10, 2021 | marketwatch.com Get VIVUS News Delivered to You Automatically Sign up to receive the latest news and ratings for VVUSQ and its competitors with MarketBeat's FREE daily newsletter. Email Address VVUSQ Media Mentions By Week VVUSQ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VVUSQ News Sentiment▼0.000.78▲Average Medical News Sentiment VVUSQ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VVUSQ Articles This Week▼00▲VVUSQ Articles Average Week Get VIVUS News Delivered to You Automatically Sign up to receive the latest news and ratings for VVUSQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Today Algernon Pharmaceuticals News Today Allstar Health Brands News Today American Premium Mining News Today Anew Medical News Today Arno Therapeutics News Today AstraZeneca News Today AVAX Technologies News Today AVVAA World Health Care Products News Today AXIM Biotechnologies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:VVUSQ) was last updated on 1/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VIVUS, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VIVUS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
